Previous studies have identified various biomarkers for dynamic monitoring, including peripheral blood circulating tumor DNA (11, 12), neutrophil-to-lymphocyte ratio (13), C-reactive protein (14), interleukin-6 (15), interleukin-8 (16, 17), CXCL8, and CXCL10 (18). Here, CXCL8 is linked to neoplasm.